You cannot test directly for tetanus. No blood, saliva, or imaging test detects the disease itself, because tetanus is a clinical diagnosis made from symptoms and a wound history. Lab tests can only measure protective antibodies from vaccination or identify the bacterium in a wound culture, and neither confirms active tetanus. A patient with a stiff jaw and muscle spasms is diagnosed at the bedside, not in the laboratory.
That gap surprises people. Most infections have a confirmatory swab, PCR, or blood culture. Tetanus is different because the harm comes from a toxin acting on nerves, not from bacteria spreading through the body. This explainer covers why the test gap exists, how antibody testing works, what wound cultures can and cannot show.
The toxin, not the bacterium, causes disease
Clostridium tetani is a spore-forming bacterium that lives in soil, dust, and animal feces. Spores enter through a break in the skin. In an oxygen-poor wound, spores germinate into active bacteria, which release a protein called tetanospasmin.
Tetanospasmin travels up motor neurons and through the bloodstream to the spinal cord and brainstem. There it blocks the release of inhibitory neurotransmitters, mainly GABA and glycine. The result is unchecked motor signaling: muscles contract and cannot relax. Blood and tissue tests cannot catch a toxin already bound inside nerve terminals. This explains why no routine diagnostic exists for the disease itself.
What antibody tests measure
Serology measures IgG antibodies against tetanus toxoid. A level of 0.1 international units per milliliter (IU/mL) or higher is the widely used protective threshold. Levels above 1.0 IU/mL indicate strong protection, while below 0.1 IU/mL suggests susceptibility.
These tests assess vaccine protection, not infection. A protected person can still develop tetanus in rare cases if a wound contains overwhelming toxin. An unvaccinated person with no symptoms may test low and still never develop disease. The test answers "would a booster help?" and not "do I have tetanus?"
Quantified context
Tetanus is rare in the United States but not gone. The CDC has recorded roughly 20 to 30 cases annually in recent decades, with a case-fatality rate near 10 to 15 percent despite intensive care. Global mortality is far higher: the World Health Organization estimated about 25,000 neonatal tetanus deaths in 2018, down from 787,000 in 1988.
Incubation typically runs 3 to 21 days, with a median around 7 to 10 days. Shorter incubation predicts more severe disease. The time course matters for exposure decisions, not for lab testing.
| Time since exposure | What clinicians watch |
|---|---|
| 0 to 24 hours | Wound cleaning and booster decision |
| 1 to 3 days | Spore germination window in deep wounds |
| 3 to 21 days | Typical incubation; symptom onset |
| 7 to 10 days | Median onset; highest vigilance |
| 14 days and beyond | Late cases still possible |
| Weeks to months | Recovery phase in survivors |
One caveat that professionals stress: the threshold of 0.1 IU/mL is a correlate of protection, not a guarantee. It was derived from population studies and is highly reliable but not absolute. Rare failures occur at levels that look adequate.
Why wound cultures fall short
A wound culture can grow C. tetani, but its absence does not rule out tetanus. Swabs recover the organism in only a minority of confirmed clinical cases. The bacterium is anaerobic and fastidious, meaning standard culture conditions may miss it. Clinicians therefore treat suspected tetanus on clinical grounds without waiting for microbiology.
Culture matters mainly in research or unusual presentations. It does not guide emergency care. If a patient has trismus, risus sardonicus (a fixed grin from facial muscle spasm), or generalized rigidity, treatment starts immediately.
Edge cases that change the picture
Neonatal tetanus presents within the first 28 days of life, usually through an unsterile umbilical stump. Diagnosis is clinical, and serology is not useful in newborns. Intravenous drug users can develop tetanus through contaminated skin wounds; antibody status may be unknown.
Immunocompromised patients may mount weak antibody responses, so a "protective" titer can overstate real-world defense. Older adults born before widespread childhood vaccination often have waning immunity. In one U.S. survey era, roughly 10 to 20 percent of adults over 70 lacked protective antibody levels.
There is no rapid point-of-care test for tetanus toxin. Emergency departments rely on history and exam. This is the professional caveat: the absence of a test is not a failure of medicine but a consequence of how the disease works.
Common misconceptions
Misconception: a blood test can confirm tetanus. Reality: diagnosis is clinical, and no routine test detects the toxin. Misconception: a positive culture means tetanus. Reality: the organism can be present without disease. Misconception: a protective titer means zero risk. Reality: overwhelming toxin exposure can rarely override immunity. Misconception: everyone needs an antibody test. Reality: vaccination history guides most decisions. Misconception: tetanus is extinct. Reality: cases still occur, and global neonatal deaths remain significant. Misconception: a rusty nail is the main cause. Reality: any contaminated or deep wound can harbor spores.
Practical actions
Check vaccination records first. Adults need a tetanus-diphtheria booster every 10 years, and tetanus-diphtheria-pertussis once if never received. For a clean, minor wound, a booster is due if more than 10 years have passed. For a dirty or deep wound, the interval shortens to 5 years. Tetanus immune globulin may be given for high-risk wounds in unvaccinated or under-vaccinated people.
Red flag: jaw stiffness or difficulty opening the mouth. Red flag: muscle spasms triggered by noise or light. Red flag: a deep puncture wound with no booster in over 5 years. Red flag: a newborn with poor feeding and rigidity.
When in doubt, seek care. Early wound cleaning with soap and water reduces risk. Antibody testing is reasonable for people with unknown vaccination history or immune compromise, but it should never delay wound care or emergency evaluation.
Limitations of testing and diagnosis
Serology reflects circulating antibody, not tissue-level protection, and results take days at reference labs. No test distinguishes a mild exposure from one that will progress. Clinical diagnosis remains the standard, and treatment decisions rest on symptoms, wound characteristics, and vaccination history.
Outcomes depend on speed. Intensive care with airway support, muscle relaxants, and antitoxin improves survival, but recovery can take weeks to months. The absence of a diagnostic test is a structural feature of tetanus. Prevention through vaccination is the only reliable control, and it is measured in titers, not in cultures.
Source: CDC surveillance data on tetanus incidence and case fatality; WHO estimates of neonatal tetanus mortality; standard serologic correlates of protection used in clinical immunology.